Buy Mannkind with Catalysts Ahead: Bank of America

Bank of America/ Merrill Lynch analyst Steve Byrne upgraded biopharmaceutical company Mannkind (MNKD) to Buy today on expectations that the drug will receive positive news in 2013 from Phase studies of its inhalable insulin treatment Afrezza. “Assuming positive phase 3 data (including new inhaler device), we model an early-2014 US approval. Given Afrezza’s low profile [...]